Bulletin
Investor Alert

Acceleron Pharma Inc.

NAS: XLRN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/203395072/composite

$

108.14

Change

0.00 0.00%

Volume

Volume 1,686

Sep 25, 2020, 4:01 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203395072/composite

Previous close

$ 105.03

$ 108.14

Change

+3.11 +2.96%

Day low

Day high

$104.13

$108.24

Open
Open: 105.76

52 week low

52 week high

$37.60

$112.89

Open

Market cap

$6.48B

Average volume

504,608

P/E ratio

N/A

Rev. per Employee

$80,873

EPS

-2.60

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/xlrn

MarketWatch News on XLRN

  1. 5 Biotech Stocks That Could Be Worth a Look

    10:44 p.m. Aug. 26, 2020

    - Barron's Online

  2. Acceleron Pharma initiated at strong buy with $155 price target at Raymond James

    8:14 a.m. Aug. 25, 2020

    - Tonya Garcia

  3. Acceleron Pharma stock jumps after positive heart-drug study

    4:29 p.m. June 24, 2020

    - Jeremy C. Owens

  4. Acceleron Pharma upgraded to overweight at Morgan Stanley

    10:50 a.m. Feb. 3, 2020

    - Tomi Kilgore

  5. Acceleron Stock Is Skyrocketing After Surprise Drug-Trial Success

    11:21 a.m. Jan. 28, 2020

    - Barron's Online

  6. Acceleron Pharma stock price target raised to $104 from $48 at SVB Leerink

    8:57 a.m. Jan. 28, 2020

    - Tomi Kilgore

  7. Acceleron Pharma stock soars more than 50% on hypertension drug study

    5:22 p.m. Jan. 27, 2020

    - Wallace Witkowski

  8. Acceleron Pharma stock rallies more than 50% on drug trial results

    5:12 p.m. Jan. 27, 2020

    - Wallace Witkowski

  9. Celgene's rare disease drug gets FDA approval

    3:24 p.m. Nov. 8, 2019

    - Jaimy Lee

  10. Acceleron Pharma stock price target cut to $55 from $62 at SVB Leerink

    7:42 a.m. Sept. 17, 2019

    - Tomi Kilgore

  11. Acceleron Pharma upgraded to outperform from perform at Oppenheimer

    8:14 a.m. April 22, 2019

    - Tomi Kilgore

  12. Celgene Buys More of This Biotech Stock

    6:05 p.m. Jan. 24, 2019

    - Barron's Online

  13. These Stocks Have the Most to Gain as U.S., China Talk Trade

    7:37 p.m. Jan. 17, 2019

    - Barron's Online

  14. Upbeat Celgene Data Not Enough to Lift Biotech Sector

    1:40 p.m. July 10, 2018

    - Barrons Blogs

  15. Celgene, Acceleron shares rise on blood-disorder drug study

    5:13 p.m. July 9, 2018

    - Wallace Witkowski

  16. Biogen’s Bump Good for Biotech

    11:06 a.m. July 9, 2018

    - Barron's Online

  17. Dow Shrugs Off Trade War, Gains on Payroll Surprise

    11:07 a.m. July 9, 2018

    - Barron's Online

  18. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/xlrn

Other News on XLRN

  1. Acceleron Looks To Next Therapy After Reblozyl Launch

    11:53 p.m. Aug. 26, 2020

    - Seeking Alpha

  2. Acceleron (XLRN) Reports Narrower-Than-Expected Q2 Loss

    10:36 a.m. Aug. 7, 2020

    - Zacks.com

  3. 10-Q: ACCELERON PHARMA INC

    4:19 p.m. Aug. 6, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  4. Notable earnings after Thursday's close

    5:35 p.m. Aug. 5, 2020

    - Seeking Alpha

  5. Acceleron Pharma Q2 2020 Earnings Preview

    5:35 p.m. Aug. 5, 2020

    - Seeking Alpha

  6. Acceleron (XLRN) in Focus: Stock Moves 5.3% Higher

    8:50 a.m. July 6, 2020

    - Zacks.com

  7. Acceleron prices stock offering at $92.50

    3:24 a.m. July 1, 2020

    - Seeking Alpha

  8. Bristol Myers & Acceleron Obtain EC Approval for Reblozyl

    11:47 a.m. June 29, 2020

    - Zacks.com

  9. Acceleron's sotatercept successful in mid-stage PAH study

    3:54 p.m. June 24, 2020

    - Seeking Alpha

  10. Small Caps Build Steam And Biotechs Remain Well-Positioned

    10:15 a.m. June 10, 2020

    - Seeking Alpha

  11. Loading more headlines...
/news/pressrelease/company/us/xlrn

Press Releases on XLRN

  1. Acceleron Appoints Laura J. Hamill to its Board of Directors

    7:00 a.m. Sept. 16, 2020

    - BusinessWire - BZX

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.